0.68
+26.47%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About AirSculpt Technologies
From its filings with the US Securities and Exchange Commission
AirSculpt Technologies is based in Tampa, Florida. Its shares trade on Nasdaq under the ticker AIRS. The SEC classifies its business as offices & clinics of doctors of medicine. In the fiscal year to 31 December 2025, it reported revenue of $151.8m and a net loss of $11.7m. At that date it held total assets of $187.3m and shareholders' equity of $87.7m.
AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
We believe our treatment results and elite patient experience have positioned AirSculpt as a preferred body contouring brand. We performed 11,852 body contouring procedures in 2025. Our proprietary and patented AirSculpt® method is minimally invasive because it requires no needle, no scalpel, no stitches and no general anesthesia to achieve transformational change that appears both natural and smooth. Our patients are guided by surgeons, nurses and patient care consultants through every step of the experience.
We have a broad offering of fat removal procedures across treatment areas. We also offer innovative fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Our innovative body contouring procedures include the Power BBL®, a Brazilian butt lift procedure, the Up a Cup™, a breast enhancement procedure, and the Hip Flip™, an hourglass contouring procedure. Our motivation to provide the best body contouring outcomes for our patients fuels our innovation.
Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 29 Oct 2021
- Employees
- 330
- Head office
- 2023 WEST PLATT STREET, TAMPA, FL, 33605
- Classification
- Services-Offices & Clinics of Doctors of Medicine
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Michael DoyleNon-Executive Chairman of the Board
- Mr. Yogesh JashnaniChief Executive Officer, Director, since 2025
- Mr. Michael ArthurChief Financial Officer
- Mr. Dennis DeanChief Financial Officer$1.2m
- Mr. Adam FeinsteinLead Independent Director
- Mr. Thomas AaronIndependent Director$252,500
- Ms. Caroline ChuIndependent Director$250,000
- Mr. Kenneth HigginsIndependent Director$257,500
- Mr. Daniel SollofIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 42
- Environment
- 48
- Social
- 36
- Governance
- 44
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Airsculpt Technologies Inc has several significant strengths that contribute to its success in the market. Firstly, the company boasts a team of highly skilled and experienced professionals who are well-versed in the latest technologies and techniques in the field of airsculpting. This expertise allows the company to deliver exceptional results and maintain a competitive edge.
- Additionally, Airsculpt Technologies Inc has built a strong reputation for its quality and innovation in the industry. The company's commitment to excellence is evident in its products and services, attracting a loyal customer base and fostering long-term relationships with clients.
Weaknesses
- Despite its strengths, Airsculpt Technologies Inc also faces certain weaknesses that should be addressed to maintain its market position. One of the key weaknesses is its relatively high pricing compared to some competitors. This may limit the company's ability to attract price-sensitive customers and expand its market share.
- Additionally, the company's geographical presence is somewhat limited, primarily serving customers in specific regions. This geographical constraint may hinder its growth potential and limit access to new markets.
Opportunities
- Airsculpt Technologies Inc has several opportunities to capitalize on in the market. With the growing demand for non-invasive cosmetic procedures, there is a significant opportunity to expand the company's offerings and target a wider range of customers. By introducing new products or variations of existing ones, the company can tap into new segments and increase its market share.
- Furthermore, advancements in technology and research provide an opportunity for Airsculpt Technologies Inc to enhance its existing products and services, ensuring it remains at the forefront of innovation in the industry.
Threats
- Airsculpt Technologies Inc faces certain threats that may impact its business operations and performance. One of the primary threats is the presence of intense competition in the market. The industry is flooded with numerous companies offering similar airsculpting products and services, creating a highly competitive environment where differentiation is crucial.
- Additionally, regulatory changes and compliance requirements pose a potential threat to the company. As governments and regulatory bodies continue to monitor and adjust regulations related to cosmetic procedures, Airsculpt Technologies Inc must adapt and comply with these changing requirements to avoid legal or reputational issues.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.